PHVS
Pharvaris N.V.
stockNASDAQ
At CloseOct 28, 2026 3:59:56 PM EDT
32.83USD+2.754%(+0.88)381,074
Pre-marketOct 28, 2026 9:10:30 AM EDT
31.85USD-0.313%(-0.10)
Loading…
Loading…
2.30B
Healthcare
Biotechnology
HQ
Leiden, Netherlands
Previous Close
$31.95
Beta
0.88
52-Week High
$43.25 2026-09-08
52-Week Low
$21.02 2025-11-07
SMA 50
$33.78
SMA 200
$30.92
Avg. Vol 10D
639,558
Avg. Vol 30D
655,496
Avg. Vol 90D
701,450
Relative Vol
0.58
70.20M
33.60M
47.86%
2,465,342
7.34%
4.01
53%/47%
41.05%
35.31%
0.2700%
550,000
50
190
Nov 11, 2026 (13d)
Oct 29, 2026
Oct 23, 2026
Pharvaris rises after BofA upgrades to Buy · 
Seeking Alpha
Oct 8, 2026
Oct 5, 2026
Sep 15, 2026
PHVS Profile
pharvaris is a preclinical stage company focused on bringing an oral bradykinin b2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (hae) and other b2 receptor-mediated indications. the company reunites the core team responsible for the discovery and approval of the hae treatment icatibant. with novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
PHVS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 30.68 | 2026-10-22 | +6.97% | -1.256 |
| 1M | 31.73 | 2026-09-29 | +3.44% | 1.471 |
| 3M | 32.62 | 2026-07-29 | +0.61% | 0.754 |
| 6M | 29.83 | 2026-04-29 | +10.02% | 0.433 |
| 1Y | 22.08 | 2025-10-29 | +48.64% | 0.878 |
| 2Y | 23.75 | 2024-10-29 | +38.19% | — |
| 5Y | 17.43 | 2021-10-29 | +88.30% | 0.644 |
PHVS Stock Summary
Pharvaris N.V. (NASDAQ:PHVS) stock price today is $32.82, and today's volume is 381,074. PHVS is up 2.723% today. The 30 day average volume is 655,496. PHVS market cap is $2.30B with 70.20M shares outstanding.